Cognitive Impairment in Multiple Sclerosis
Multiple sclerosis (MS) is a socially significant immune-mediated disease, characterized by demyelination, axonal transection and oligodendropathy in the central nervous system. Inflammatory demyelination and neurodegeneration lead to brain atrophy and cognitive deficit in up to 75% of the patients....
Gespeichert in:
| Veröffentlicht in: | Folia Medica 2016-09, Vol.58 (3), p.157-163 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 163 |
|---|---|
| container_issue | 3 |
| container_start_page | 157 |
| container_title | Folia Medica |
| container_volume | 58 |
| creator | Trenova, Anastasiya G Slavov, Georgi S Manova, Maria G Aksentieva, Jana B Miteva, Lyuba D Stanilova, Spaska A |
| description | Multiple sclerosis (MS) is a socially significant immune-mediated disease, characterized by demyelination, axonal transection and oligodendropathy in the central nervous system. Inflammatory demyelination and neurodegeneration lead to brain atrophy and cognitive deficit in up to 75% of the patients. Cognitive dysfunctions impact significantly patients' quality of life, independently from the course and phase of the disease. The relationship between pathological brain findings and cognitive impairment is a subject of intensive research. Summarizing recent data about prevalence, clinical specificity and treatment of cognitive disorders in MS, this review aims to motivate the necessity of early diagnosis and complex therapeutic approach to these disturbances in order to reduce the social burden of the disease. |
| doi_str_mv | 10.1515/folmed-2016-0029 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_proquest_miscellaneous_1835495211</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_fcc3213e89fb4bf881a5e0f1309ccefe</doaj_id><sourcerecordid>1835495211</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4057-acfcb44b05893f8d9ce80127b81e35272684b2aa51cb3e0dd790699e035141143</originalsourceid><addsrcrecordid>eNpdkUuLFDEURoMoTju6dyUNbkQovTePqmQpjY-GERfqOqRSN0OaqkqbVAnz703ZMy5cBZJzv3zJYewlwjtUqN6HNE40NBywbQC4ecR2KFA2HKV4zHbAQTYapLhiz0o5AbQKQD1lV7zrWgDkO_b2kG7nuMTftD9OZxfzRPOyj_P-6zou8TzS_rsfKacSy3P2JLix0Iv79Zr9_PTxx-FLc_Pt8_Hw4abxElTXOB98L2UPShsR9GA86XpV12skoXjHWy177pxC3wuCYegMtMYQCIUSa_FrdrzkDsmd7DnHyeU7m1y0fzdSvrUuL7HWssF7wVGQNqGXfdAanSIIKMB4T4Fq1ptL1jmnXyuVxU6xeBpHN1Nai0UtlDSKI1b09X_oKa15ri_dKIFCKWMqBRfK1z8pmcK_ggh2c2IvTuzmxG5O6sir--C1304eBh4kiD_fPoXM</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1833135599</pqid></control><display><type>article</type><title>Cognitive Impairment in Multiple Sclerosis</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Trenova, Anastasiya G ; Slavov, Georgi S ; Manova, Maria G ; Aksentieva, Jana B ; Miteva, Lyuba D ; Stanilova, Spaska A</creator><creatorcontrib>Trenova, Anastasiya G ; Slavov, Georgi S ; Manova, Maria G ; Aksentieva, Jana B ; Miteva, Lyuba D ; Stanilova, Spaska A</creatorcontrib><description>Multiple sclerosis (MS) is a socially significant immune-mediated disease, characterized by demyelination, axonal transection and oligodendropathy in the central nervous system. Inflammatory demyelination and neurodegeneration lead to brain atrophy and cognitive deficit in up to 75% of the patients. Cognitive dysfunctions impact significantly patients' quality of life, independently from the course and phase of the disease. The relationship between pathological brain findings and cognitive impairment is a subject of intensive research. Summarizing recent data about prevalence, clinical specificity and treatment of cognitive disorders in MS, this review aims to motivate the necessity of early diagnosis and complex therapeutic approach to these disturbances in order to reduce the social burden of the disease.</description><identifier>ISSN: 0204-8043</identifier><identifier>ISSN: 1314-2143</identifier><identifier>EISSN: 1314-2143</identifier><identifier>DOI: 10.1515/folmed-2016-0029</identifier><identifier>PMID: 27760012</identifier><language>eng</language><publisher>Bulgaria: MEDICAL UNIVERSITY- PLOVDIV</publisher><subject>Central Nervous System - pathology ; Cognitive Dysfunction - etiology ; Cognitive Dysfunction - pathology ; Cognitive Dysfunction - therapy ; cognitive impairment ; Disease Progression ; Humans ; multiple sclerosis ; Multiple Sclerosis - complications ; Multiple Sclerosis - pathology ; neuropsychological tests ; Quality of Life</subject><ispartof>Folia Medica, 2016-09, Vol.58 (3), p.157-163</ispartof><rights>Copyright MEDICAL UNIVERSITY- PLOVDIV 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4057-acfcb44b05893f8d9ce80127b81e35272684b2aa51cb3e0dd790699e035141143</citedby><cites>FETCH-LOGICAL-c4057-acfcb44b05893f8d9ce80127b81e35272684b2aa51cb3e0dd790699e035141143</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27760012$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Trenova, Anastasiya G</creatorcontrib><creatorcontrib>Slavov, Georgi S</creatorcontrib><creatorcontrib>Manova, Maria G</creatorcontrib><creatorcontrib>Aksentieva, Jana B</creatorcontrib><creatorcontrib>Miteva, Lyuba D</creatorcontrib><creatorcontrib>Stanilova, Spaska A</creatorcontrib><title>Cognitive Impairment in Multiple Sclerosis</title><title>Folia Medica</title><addtitle>Folia Med (Plovdiv)</addtitle><description>Multiple sclerosis (MS) is a socially significant immune-mediated disease, characterized by demyelination, axonal transection and oligodendropathy in the central nervous system. Inflammatory demyelination and neurodegeneration lead to brain atrophy and cognitive deficit in up to 75% of the patients. Cognitive dysfunctions impact significantly patients' quality of life, independently from the course and phase of the disease. The relationship between pathological brain findings and cognitive impairment is a subject of intensive research. Summarizing recent data about prevalence, clinical specificity and treatment of cognitive disorders in MS, this review aims to motivate the necessity of early diagnosis and complex therapeutic approach to these disturbances in order to reduce the social burden of the disease.</description><subject>Central Nervous System - pathology</subject><subject>Cognitive Dysfunction - etiology</subject><subject>Cognitive Dysfunction - pathology</subject><subject>Cognitive Dysfunction - therapy</subject><subject>cognitive impairment</subject><subject>Disease Progression</subject><subject>Humans</subject><subject>multiple sclerosis</subject><subject>Multiple Sclerosis - complications</subject><subject>Multiple Sclerosis - pathology</subject><subject>neuropsychological tests</subject><subject>Quality of Life</subject><issn>0204-8043</issn><issn>1314-2143</issn><issn>1314-2143</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DOA</sourceid><recordid>eNpdkUuLFDEURoMoTju6dyUNbkQovTePqmQpjY-GERfqOqRSN0OaqkqbVAnz703ZMy5cBZJzv3zJYewlwjtUqN6HNE40NBywbQC4ecR2KFA2HKV4zHbAQTYapLhiz0o5AbQKQD1lV7zrWgDkO_b2kG7nuMTftD9OZxfzRPOyj_P-6zou8TzS_rsfKacSy3P2JLix0Iv79Zr9_PTxx-FLc_Pt8_Hw4abxElTXOB98L2UPShsR9GA86XpV12skoXjHWy177pxC3wuCYegMtMYQCIUSa_FrdrzkDsmd7DnHyeU7m1y0fzdSvrUuL7HWssF7wVGQNqGXfdAanSIIKMB4T4Fq1ptL1jmnXyuVxU6xeBpHN1Nai0UtlDSKI1b09X_oKa15ri_dKIFCKWMqBRfK1z8pmcK_ggh2c2IvTuzmxG5O6sir--C1304eBh4kiD_fPoXM</recordid><startdate>20160901</startdate><enddate>20160901</enddate><creator>Trenova, Anastasiya G</creator><creator>Slavov, Georgi S</creator><creator>Manova, Maria G</creator><creator>Aksentieva, Jana B</creator><creator>Miteva, Lyuba D</creator><creator>Stanilova, Spaska A</creator><general>MEDICAL UNIVERSITY- PLOVDIV</general><general>Pensoft Publishers</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>4U-</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BYOGL</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>20160901</creationdate><title>Cognitive Impairment in Multiple Sclerosis</title><author>Trenova, Anastasiya G ; Slavov, Georgi S ; Manova, Maria G ; Aksentieva, Jana B ; Miteva, Lyuba D ; Stanilova, Spaska A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4057-acfcb44b05893f8d9ce80127b81e35272684b2aa51cb3e0dd790699e035141143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Central Nervous System - pathology</topic><topic>Cognitive Dysfunction - etiology</topic><topic>Cognitive Dysfunction - pathology</topic><topic>Cognitive Dysfunction - therapy</topic><topic>cognitive impairment</topic><topic>Disease Progression</topic><topic>Humans</topic><topic>multiple sclerosis</topic><topic>Multiple Sclerosis - complications</topic><topic>Multiple Sclerosis - pathology</topic><topic>neuropsychological tests</topic><topic>Quality of Life</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Trenova, Anastasiya G</creatorcontrib><creatorcontrib>Slavov, Georgi S</creatorcontrib><creatorcontrib>Manova, Maria G</creatorcontrib><creatorcontrib>Aksentieva, Jana B</creatorcontrib><creatorcontrib>Miteva, Lyuba D</creatorcontrib><creatorcontrib>Stanilova, Spaska A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>East Europe, Central Europe Database</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Folia Medica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Trenova, Anastasiya G</au><au>Slavov, Georgi S</au><au>Manova, Maria G</au><au>Aksentieva, Jana B</au><au>Miteva, Lyuba D</au><au>Stanilova, Spaska A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cognitive Impairment in Multiple Sclerosis</atitle><jtitle>Folia Medica</jtitle><addtitle>Folia Med (Plovdiv)</addtitle><date>2016-09-01</date><risdate>2016</risdate><volume>58</volume><issue>3</issue><spage>157</spage><epage>163</epage><pages>157-163</pages><issn>0204-8043</issn><issn>1314-2143</issn><eissn>1314-2143</eissn><abstract>Multiple sclerosis (MS) is a socially significant immune-mediated disease, characterized by demyelination, axonal transection and oligodendropathy in the central nervous system. Inflammatory demyelination and neurodegeneration lead to brain atrophy and cognitive deficit in up to 75% of the patients. Cognitive dysfunctions impact significantly patients' quality of life, independently from the course and phase of the disease. The relationship between pathological brain findings and cognitive impairment is a subject of intensive research. Summarizing recent data about prevalence, clinical specificity and treatment of cognitive disorders in MS, this review aims to motivate the necessity of early diagnosis and complex therapeutic approach to these disturbances in order to reduce the social burden of the disease.</abstract><cop>Bulgaria</cop><pub>MEDICAL UNIVERSITY- PLOVDIV</pub><pmid>27760012</pmid><doi>10.1515/folmed-2016-0029</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0204-8043 |
| ispartof | Folia Medica, 2016-09, Vol.58 (3), p.157-163 |
| issn | 0204-8043 1314-2143 1314-2143 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1835495211 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Central Nervous System - pathology Cognitive Dysfunction - etiology Cognitive Dysfunction - pathology Cognitive Dysfunction - therapy cognitive impairment Disease Progression Humans multiple sclerosis Multiple Sclerosis - complications Multiple Sclerosis - pathology neuropsychological tests Quality of Life |
| title | Cognitive Impairment in Multiple Sclerosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T18%3A34%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cognitive%20Impairment%20in%20Multiple%20Sclerosis&rft.jtitle=Folia%20Medica&rft.au=Trenova,%20Anastasiya%20G&rft.date=2016-09-01&rft.volume=58&rft.issue=3&rft.spage=157&rft.epage=163&rft.pages=157-163&rft.issn=0204-8043&rft.eissn=1314-2143&rft_id=info:doi/10.1515/folmed-2016-0029&rft_dat=%3Cproquest_doaj_%3E1835495211%3C/proquest_doaj_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1833135599&rft_id=info:pmid/27760012&rft_doaj_id=oai_doaj_org_article_fcc3213e89fb4bf881a5e0f1309ccefe&rfr_iscdi=true |